Helius pivots to Solana with $500M crypto treasury raise
What's the deal? Helius Medical TechnologiesDealroom has a profile for this one. Try Dealroom → (Nasdaq: HSDT) has raised $500 million in a post-IPO equity offering to launch a Solana treasury company. Pantera Capital and Summer CapitalDealroom has a profile for this one. Try Dealroom → led the round, joined by Big Brain HoldingsDealroom has a profile for this one. Try Dealroom →, AvenirDealroom has a profile for this one. Try Dealroom →, SinoHopeDealroom has a profile for this one. Try Dealroom →, FalconX, Arrington CapitalDealroom has a profile for this one. Try Dealroom →, Animoca Brands, Aspen DigitalDealroom has a profile for this one. Try Dealroom →, BorderlessDealroom has a profile for this one. Try Dealroom →, Laser DigitalDealroom has a profile for this one. Try Dealroom →, HashKey CapitalDealroom has a profile for this one. Try Dealroom →, and Republic DigitalDealroom has a profile for this one. Try Dealroom →.
What's the endgame? The company will use net proceeds to build a digital asset treasury, making SOL — Solana's native cryptocurrency — its primary reserve asset. Helius plans to tap the network's roughly 7% native staking yield and pursue DeFi opportunities, a contrast to non-yield-bearing assets like Bitcoin.
Why now? The oversubscribed private placement priced shares at $6.881, with stapled warrants exercisable at $10.134 over three years. Closing was expected on or about September 18, 2025.
The offering could deliver over $1.25 billion if warrants are exercised, according to the company.
Who's running it? The treasury strategy was set to be led by incoming director and executive chairman Joseph Chee, founder of Summer Capital and former head of investment banking, Asia at UBSDealroom has a profile for this one. Try Dealroom →. Pantera general partner Cosmo Jiang joined as board observer, with Pantera founder Dan Morehead as advisor.
"We believe that Solana is a category-defining blockchain and the foundation on which a new financial system will be built," Morehead said.
The signal: At $500 million, the deal ranks in the 97th percentile of all post-IPO equity rounds for US health companies. It marks another entrant in the growing field of public companies converting balance sheets into crypto treasuries — this time betting on Solana rather than Bitcoin.
Read more: QubeMark
Image credit: Helius Medical Technologies
